All News
Elon Musk’s Neuralink raises $650 mn in latest funding as clinical trials begin
Neuralink closed its funding round with participation from key investors including ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, QIA, Sequoia Capital, Thrive Capital, Valor Eq
Read MoreOpinion: STAT+: 4 ideas to kick-start U.S. drug research — and beat China in biotech
“There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising safety,” write Brian Finrow and Sandeep Patel.
Read More‘The safety net of the safety net’: Why education and transportation cuts are also public health cuts
Massachusetts health commissioner Robbie Goldstein says threats to public health funding are being felt nationwide
Read MoreOpinion: The two very different types of mental health stigma
Psychosis and depression carry very different types of stigma, and acknowledging that is crucial to advocacy campaigns.
Read MoreThe U.S. slashed HIV/AIDS funding. Here is how countries that relied on it might adapt
Of 49 countries surveyed in a recent analysis, 15 have historically relied on the the U.S. for most of the funding for their HIV/AIDS responses.
Read MoreEating disorder research defunded despite MAHA focus on chronic conditions
Experts on eating disorders like anorexia worry that research funding cuts mean patients won't get the care they need.
Read MoreOliver Wyman appoints Dr Chirag Adatia as Partner in Health & Life Sciences and Private Capital practices
Dr Adatia brings over 18 years of extensive experience in healthcare strategy and digital transformation
Read MoreAnorexia in Middle Age and Beyond
A growing number of older women are seeking treatment for eating disorders. Many have struggled without help for decades.
Read MoreMember States reaffirm commitment to WHO and global health at 78th World Health Assembly
The first global agreement to make the world safer from future pandemics was adopted, in addition to an increase in financial support to the World Health Organization
Read MoreUK cancer survival rate doubles since 1970s amid ‘golden age’, report says
Half of those diagnosed will now survive for 10 years or more after advances in diagnosis and treatmentThe proportion of people surviving cancer in the UK has doubled since the 1970s amid a “golden
Read More